SMTL ID : 5t45.1

Chicken smooth muscle myosin motor domain co-crystallized with the specific CK-571 inhibitor, MgADP.BeFx form

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x 52E: 4-{[(2-chloro-3-fluorobenzyl)carbamoyl](methyl)amino}-3,4-dideoxy-5-O-(isoquinolin-3-ylcarbamoyl)-D-erythro-pentitol(Non-covalent)

52E.1: 21 residues within 4Å: Chain A: M.89, A.90, L.95, V.100, S.117, G.118, L.119, F.120, F.493, N.494, M.497, E.501, F.517, G.709, V.710, E.712, G.713, I.714, C.717, P.722, R.724 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.95, A:F.493, A:F.493, A:M.497, A:F.517, A:I.714 Hydrogen bonds: A:G.118, A:L.119, A:P.722 Water bridges: A:M.89, A:A.90, A:R.724

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 5 residues within 4Å: Chain A: T.184, S.246, D.465 Ligands: BEF.3, ADP.4 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:T.184, A:S.246, H2O.1, H2O.1

1 x BEF: BERYLLIUM TRIFLUORIDE ION(Non-covalent)

BEF.3: 9 residues within 4Å: Chain A: S.179, G.180, K.183, T.184, N.242, S.245, S.246 Ligands: MG.2, ADP.4 No protein-ligand interaction detected (PLIP)

1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.4: 18 residues within 4Å: Chain A: I.113, N.125, P.126, Y.127, K.128, Y.133, E.178, S.179, G.180, A.181, G.182, K.183, T.184, E.185, N.242, N.244 Ligands: MG.2, BEF.3 18 PLIP interactions: 18 interactions with chain A Hydrogen bonds: A:N.125, A:Y.133, A:E.178, A:E.178, A:G.180, A:A.181, A:G.182, A:K.183, A:T.184, A:T.184, A:E.185, A:N.242, A:N.242 Water bridges: A:N.244, A:N.244, A:S.246, A:S.246 Salt bridges: A:K.183

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.5: 10 residues within 4Å: Chain A: S.246, R.247, F.248, G.249, Y.270, L.271, E.273, I.466, A.467, I.482 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:L.271, A:E.273 Water bridges: A:R.247, A:E.273 GOL.6: 5 residues within 4Å: Chain A: Y.161, V.197, S.199, T.259, Y.261 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:V.197, A:T.259 GOL.7: 4 residues within 4Å: Chain A: Y.586, R.706, E.712, R.715 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.715

1 x BCN: BICINE(Non-covalent)

BCN.8: 8 residues within 4Å: Chain A: F.251, R.253, E.268, Y.270, Q.666, K.669, L.670, T.673 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:R.253, A:E.268, A:Y.270, A:Q.666, A:T.673, A:T.673 Water bridges: A:N.266, A:N.266 Salt bridges: A:K.669

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sirigu, S. et al., Highly selective inhibition of myosin motors provides the basis of potential therapeutic application. Proc. Natl. Acad. Sci. U.S.A. (2016)

Release Date

2016-11-16

Peptides

Myosin-11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Myosin-11